XENE · Xenon Pharmaceuticals Inc.
Market Cap
$5.81B
Shares
96.84M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2020-08-06 | 2022-03-01 | $400,000,000 | — | — | 8-K , filed 2026-02-27 |
Key facts
CIK
1582313
CUSIP
98420N105
13F (30d)
279 filings
266 filers
Visit website
Investor relations